Skip to main content

Table 1 Subject demographics, lung function, symptom scores, imaging parameters, blood and sputum measurements

From: Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease

Variables

Healthy

S-COPD

NS-COPD (Biomass smoke)

NS-COPD (Occupational)a

S-COPD Vs. BS-COPD

S-COPD Vs. NS-COPD (Occupational)

BS-COPD Vs. NS-COPD (Occupational)

 

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

   

N

118

79

59

34

   

Sex (M: F)

53%: 47%

100%: 0%

0%: 100%

100%: 0%

   

Age (Years)

64.4 ± 7.8

67.2 ± 7.4

62.4 ± 7.3

66.7 ± 8.1

< 0.0001

p = ns

0.010

BMI (kg/m2)

21.9 ± 3.8

19.3 ± 3.4

21.3 ± 4.4

20.0 ± 3.3

0.002

p = ns

p = ns

Spirometry

 FEV1 Pre (% Predicted)

99.4 ± 14.7

43.1 ± 17.8

39.9 ± 12.4

41.9 ± 14.4

p = ns

p = ns

p = ns

 FVC Pre (% Predicted)

102.1 ± 16.8

63.6 ± 20.5

57.9 ± 16.04

62.6 ± 19.2

0.005

0.732

0.032

 Δ Reversibility FEV1 Absolute (mL)

40.0 ± 93

160.0 ± 154.0

160 ± 130

170 ± 190

p = ns

p = ns

p = ns

 Δ Reversibility FEV1%

2.2 ± 4.9

19.0 ± 19.9

25.6 ± 24.1

19.3 ± 20.6

p = ns

p = ns

p = ns

 Δ Reversibility FVC Absolute (mL)

0.0 ± 190.0

237.0 ± 312.0

240 ± 230

290 ± 300

p = ns

p = ns

p = ns

 Δ Reversibility FVC %

0.3 ± 7.4

15.5 ± 22.6

23.2 ± 31.5

18.2 ± 22.2

p = ns

p = ns

p = ns

 FEV1/FVC Post bronchodilator (%)

80.5 ± 6.1

53.1 ± 10.9

56.4 ± 8.2

52.8 ± 9.9

0.045

p = ns

0.051

 PEF (% Predicted)

89.2 ± 16.0

34.5 ± 15.8

29.8 ± 11.2

34.9 ± 24.3

p = ns

p = ns

p = ns

 FEF25–75 Pre % Predicted

65.7 ± 24.4

15.3 ± 7.4

12.8 ± 6.9

14.8 ± 7.4

p = ns

p = ns

p = ns

Plethysmography

 TLC Pre (% Predicted)

84.2 ± 15.9

104.1 ± 23.1

99.8 ± 32.6

103.2 ± 27.3

p = ns

p = ns

p = ns

 RV Pre (% Predicted)

98.8 ± 26.4

180.8 ± 65.09

176.2 ± 72.1

174.2 ± 59.6

p = ns

p = ns

p = ns

 IC Pre (% Predicted)

75.2 ± 27.3

49.6 ± 18.7

49.8 ± 23.7

43.7 ± 19.3

p = ns

p = ns

p = ns

 RV/TLC Pre (% Predicted)

116.8 ± 21.4

171.5 ± 29.7

170.9 ± 39.4

175.7 ± 31.2

p = ns

p = ns

p = ns

 SGaw Pre (% Predicted)

159.6 ± 78.0

36.2 ± 21.0

24.5 ± 13.6

26.9 ± 16.3

0.010

p = ns

p = ns

IOS

 R5 (kPa s L−1) Pre (% Predicted)

148 ± 74.8

231.8 ± 96.4

287.3 ± 100.1

244.2 ± 93.5

0.005

p = ns

p = ns

 R20 (kPa s L− 1) Pre (% Predicted)

118.0 ± 50.6

130.1 ± 44.6

158.3 ± 51.2

134.6 ± 47.1

0.012

p = ns

p = ns

 R5-R20 (kPa s L− 1) Pre

0.16 ± 0.1

0.36 ± 0.2

0.60 ± 0.3

0.39 ± 0.2

< 0.0001

p = ns

0.003

 X5 Pre (kPa s L− 1)

−0.24 ± 0.2

− 0.56 ± 0.3

−0.9 ± 0.4

−0.7 ± 0.3

< 0.0001

p = ns

p = ns

 Ax Pre (Hz kPa s L− 1)

1.96 ± 2.0

5.59 ± 3.5

10.3 ± 5.7

7.1 ± 3.7

< 0.0001

p = ns

0.034

 RF Pre (Hz)

22.4 ± 6.9

33.4 ± 7.5

37.2 ± 7.4

38.1 ± 10.0

0.022

0.041

p = ns

Gas Diffusion

 DLCo % Predicted

76.7 ± 17.3

54.2 ± 21.9

54.7 ± 17.3

70.2 ± 27.0

p = ns

p = ns

p = ns

 DLCO / VA

102.5 ± 17.6

79.9 ± 30.3

83.5 ± 15.9

96.2 ± 32.4

p = ns

p = ns

p = ns

HRCT

 Normal (%)

4.3%

0%

2.4%

0%

   

 Airways Disease Predominant (%)

59.6%

60.5%

95.2%

71.4%

   

 ILD Predominant (%)

34.0%

10.5%

0%

3.6%

   

 Emphysema Predominant (%)

2.1%

28.9%

1 (2.4%)

25.0%s

   

 Emphysema Score

19.9 ± 38.9

265 ± 342

39.6 ± 69.9

193.4 ± 313.9

0.001

p = ns

0.006

 ↓attenuation on the expiratory CT Score

164.3 ± 169.7

278.9 ± 237.8

479.5 ± 232.7

422 ± 329.1

0.001

0.024

p = ns

 CAT Score

 

23.6 ± 7.8

22.0 ± 6.5

25.2 ± 8.8

p = ns

p = ns

p = ns

 SGRQ Score

 

63.5 ± 18.5

60.2 ± 18.4

59.7 ± 16.3

p = ns

p = ns

p = ns

 CRP (mg/L)

2.3 ± 2.9

3.6 ± 4.6

5.2 ± 6.7

4.3 ± 3.9

p = ns

p = ns

p = ns

 Serum Insulin (μIU/mL)

5.5 ± 3.2

3.7 ± 2.7

8.8 ± 4.7

5.3 ± 5.6

0.008

p = ns

p = ns

 Hemoglobin (mg/dL)

12.8 ± 1.2

13.6 ± 2.3

11.9 ± 1.9

13.0 ± 2.0

< 0.0001

p = ns

p = ns

 Red cell count (106 cells/μL)

4.3 ± 0.5

4.6 ± 0.6

4.3 ± 0.4

4.6 ± 0.5

0.007

p = ns

p = ns

 Packed cell volume (%)

39.6 ± 5.2

41.8 ± 6.4

36.7 ± 5.3

40.1 ± 5.8

< 0.0001

p = ns

0.051

 Mean corpuscular volume (fL)

92.4 ± 11.2

91.4 ± 10.8

84.7 ± 10.8

88.2 ± 9.8

0.004

p = ns

p = ns

 Blood eosinophils (%)

4.6 ± 3.9

4.7 ± 4.7

5.3 ± 4.7

4.6 ± 4.43

p = ns

p = ns

p = ns

 Blood eosinophils (cells/μL)

330.4 ± 319

343.5 ± 408

410.03 ± 403.73

337.5 ± 330.09

p = ns

p = ns

p = ns

Sputum

 Total cell count per ml

1.38 (0.9 2.9)

6.19 (3.2, 9.3)

4.51 (2.5, 6.9)

3.6 (2.4, 7.4)

p = ns

p = ns

p = ns

 Macrophages per ml

0.33 (0.2, 0.6)

0.87 (0.4, 1.2)

0.72 (0.4, 1.3)

0.60 (0.3, 0.9)

p = ns

p = ns

p = ns

 Neutrophils per ml

0.87 (0.5, 2.8)

5.22 (2.6, 8.3)

2.63 (1.7, 5.9)

2.60 (1.2, 6.7)

p = ns

p = ns

p = ns

 Eosinophils per ml

0.006 (0.0, 0.02)

0.139 (0.04, 0.3)

0.25 (0.04, 0.4)

0.21 (0.1, 0.6)

p = ns

p = ns

p = ns

 Lymphocytes per ml

0.014 (0.0, 0.03)

0.032 (0.02, 0.08)

0.03 (0.01, 0.07)

0.03 (0.01, 0.05)

p = ns

p = ns

p = ns

  1. aOut of the 34 occupational COPD, 25 were farmers, 4 were farmers + hard rock mining/sandblasting exposure and 5 had occupational dust exposures for at least 20 years
  2. FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, FEF25–75 Forced expiratory flow between 25 and 75% of FVC, PEF Peak expiratory flow, BD Bronchodilator, p-y Pack-years, h-y hour-years, sRaw specific airway resistance, sGaw specific airway conductance, TLC Total lung capacity, RV Residual volumeM, IOS Impulse oscillometry, R5 Resistance at 5 Hz, X5 Reactance at 5 Hz, AX Area under the reactance curve, Fres Resonant frequency, DLCO Diffusing lung co-efficient for carbon monoxide, KCO Transfer coefficient, SGRQ St. George’s Respiratory Questionnaire, CAT COPD assessment test, hsCRP high sensitivity C-reactive protein
  3. Data are presented as means ± SD